Print Page | Contact Us | Report Content Issues | Sign In | Become a Member
ISEV2017 IOC
Share |
 

ISEV 2017 Home | Hotel/Travel | Abstracts | Program & Speakers | Sponsors & Exhibits | Registration | Welcome Letter | Scholarship | ISEV2017 IOC

Education Day | Plenary Speakers | Meet the Expert | Satellite Events

 

Meet the ISEV2017 International Organising Committee (IOC):

The IOC for ISEV2017 is committed to bringing together the best educational and scientific content for this event.

IOC Members:

 

 

Susmita Sahoo (IOC Chair), PhD is an Assistant Professor of Medicine, Cardiology at the Icahn School of Medicine at Mount Sinai, New York, NY, USA.  Her research focuses on: Stem Cells, Exosomes and Epitranscriptome in Cardiovascular Regenerative Medicine. For more information, please click HERE

 

 

Eric Boilard, PhD, is Associate Professor at Université Laval and CHU Research Center (Quebec City, Canada), in the department of Infectious Diseases and Immunity. For his research. Dr Boilard evaluates the contribution of platelets and their microvesicles in inflammatory conditions, such as rheumatic diseases and transfusion-induced adverse reactions. For more information, please click HERE.

 

 

Dave Carter, PhD, is a Reader in Biomedical Science at Oxford Brookes University in the UK. His interests are in the role of EVs during stress response and the mechanisms of EV uptake. For more information, please click HERE.

   

Uta Erdbrügger, MD, is an Assistant Professor of University of Virginia Health System, Charlottesville, USA. As a physician scientist she is interested in translational research to study the role of extracellular vesicles in renal diseases and hypertension. A second major research focus has been the improvement of detection techniques of EVs as novel biomarkers in the circulation and in urine.

 

 

Thomas Kislinger, PhD, is a Senior Scientist at the Princess Margaret Cancer Centre and an Associate Professor and Vice Chair (biology) at the University of Toronto in the Department of Medical Biophysics. The Kislinger lab applies proteomics technologies to translational and basic questions in cancer biology. This includes the development of novel proteomics methodologies, identification of liquid biopsy signatures and the molecular identification of novel cell surface markers.

 

 

Suresh Mathivanan, PhD, is from La Trobe University in Melbourne, Australia. His research interests are in understanding the biogenesis of extracellular vesicles (EVs), role of EVs in cancer progression, chemoresistance and cross-species signaling. His lab is also interested in developing bioinformatics tools to enhance EV research.

   

Matias Ostrowski is from the INBIRS Institute, at University of Buenos Aires, Argentina. The ongoing research in Dr. Ostrowski’s laboratory focuses on the molecular mechanisms underlying HIV assembly and EV biogenesis and the immunopathogenic role of EVs during HIV infection.

 

 

Janusz Rak, MD, PhD, is a Professor from McGill University in Montreal, Canada. His research interests in extracellular vesicles concentrate on their role in aberrant intercellular communication and vascular pathologies associated with genetic tumour progression.

 

Olga Volpert, PhD, is an Associate Professor at MD Anderson Cancer Center in Houston, USA. Dr. Volpert is interested in the functions of extracellular vesicles (EVs) in cancer progression and metastasis, especially their effect on cancer immune surveillance and myeloid derived suppressor cells.

  Andrew Hill (ISEV President), PhD, is a Professor and the Director of the La Trobe Institute for Molecular Sciences at La Trobe University in Melbourne, Australia.  He heads a laboratory focusing on the molecular basis of neurodegenerative disorders including prion, Alzheimer's and Parkinson's diseases.  His research interests include studying how EVs play a role in the spreaking of misfolded proteins associated with these diseases and investigating the potential for EV based diagnostics.  For more information, please click HERE.  
 

Kenneth W. Witwer (ISEV Secretary General), PhD, is an Assistant Professor in the Department of Molecular and Comparative Pathobiology at the Johns Hopkins University School of Medicine. He completed his education at Penn State University and Johns Hopkins. Dr. Witwer's lab investigates biomarkers of HIV disease, cancers, and rare diseases and seeks to develop small RNA-based therapies. Dr. Witwer is also interested in the influence of diet on extracellular vesicles and small RNA profiles.

   

Marca Wauben (ISEV Science and Meetings Chair), PhD (Utrecht University, Utrecht, The Netherlands)

 

Edit Buzas (ISEV Education Chair) MD, PhD & DSc, is a Professor and Chairman at the Department of Genetics, Cell- and Immunobiology at Semmelweis University, Budapest, Hungary. Her group has shown that EVs and protein aggregates share biophysical parameters, and EVs associate with glycosidases. Her group introduced the use of differential detergent lysis and determination of protein to lipid ratio in EV research. She is member of the Executive Committee of ISEV, Associate Editor of the Journal of Extracellular Vesicles, and Work Group leader of the European Network on Microvesicles and Exosomes in Health and Disease (Me-Had).

 

 

Dolores Di Vizio (ISEV Communications Chair), MD, PhD, isan Associate Professor at Cedars-Sinai Medical Center, and UCLA, Los Angeles.  Dr. Di Vizio's group studies the molecular mechanisms of progression to advanced disease in human tumors, with a particular emphasis on the role of large oncosomes, extracellular vesicles released from fast migrating and metastatic amoeboid cancer cells.  Her lab is currently profiling the large oncosomes by NGS and proteomics.

The IOC committee includes several ISEV Board members, acting in an advisory capacity.  All of them have experience in planning previous ISEV Conferences.